Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Levodropropizine | 99291-25-5 | MFCD00866852 | 99.7% | 10 G
SDP

Catalog No. 5000409796
Encompass_Preferred

Levodropropizine (DF-526) is an orally active histamine receptor inhibitor, described as an effective and very well tolerated peripheral antitussive agent. It also suppresses seizure activity and reduces plasma extravasation in rat models.

  • Orally active histamine receptor inhibitor.
  • Effective peripheral antitussive agent.
  • Well tolerated.
  • Inhibits seizure activity.
  • Reduces plasma extravasation.
  • Treats cough in adults and children.
  • Attenuates chronic cigarette smoke-exposure enhanced cough in guinea pigs.
  • Suppresses seizure activity in rats with pentylenetetrazol-induced epilepsy.

Catalog No. 50-004-09796 Supplier Medchemexpress LLC Supplier No. HYB189510G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Levodropropizine (DF-526) is an orally active histamine receptor inhibitor, described as an effective and very well tolerated peripheral antitussive agent. It also suppresses seizure activity and reduces plasma extravasation in rat models.

  • Orally active histamine receptor inhibitor.
  • Effective peripheral antitussive agent.
  • Well tolerated.
  • Inhibits seizure activity.
  • Reduces plasma extravasation.
  • Treats cough in adults and children.
  • Attenuates chronic cigarette smoke-exposure enhanced cough in guinea pigs.
  • Suppresses seizure activity in rats with pentylenetetrazol-induced epilepsy.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.